▶ 調査レポート

世界の硝子体内(IVT)注射剤市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global Intravitreal (IVT) Injectables Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

が調査・発行した産業分析レポートです。世界の硝子体内(IVT)注射剤市場 2021:企業別、地域別、種類・用途別 / Global Intravitreal (IVT) Injectables Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026 / GIR-105X09708資料のイメージです。• レポートコード:GIR-105X09708
• 出版社/出版日: / 2021年5月
• レポート形態:英文、PDF、104ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:Medical Devices & Consumables
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、硝子体内(IVT)注射剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。硝子体内(IVT)注射剤の種類別市場規模(抗VEGF、コルチコステロイド、抗生物質、抗ウイルス剤、抗真菌剤)、用途別市場規模(病院薬局、小売薬局、ドラッグストア、通信販売薬局、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・硝子体内(IVT)注射剤の市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):Regeneron Pharmaceuticals、Bausch & Lomb、Novartis、Allergan、Alimera Sciences、ThromboGenics、Bristol-Myers Squibb
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:抗VEGF、コルチコステロイド、抗生物質、抗ウイルス剤、抗真菌剤
・用途別分析2016年-2026年:病院薬局、小売薬局、ドラッグストア、通信販売薬局、その他
・硝子体内(IVT)注射剤の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・硝子体内(IVT)注射剤のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・硝子体内(IVT)注射剤のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・硝子体内(IVT)注射剤の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・硝子体内(IVT)注射剤の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Intravitreal (IVT) Injectables market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Intravitreal (IVT) Injectables size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Intravitreal (IVT) Injectables market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Intravitreal (IVT) Injectables market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Anti-VEGF
Corticosteroids
Antibiotics
Antivirals
Antifungals

Market segment by Application can be divided into
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Mail Order Pharmacies
Others

The key market players for global Intravitreal (IVT) Injectables market are listed below:
Regeneron Pharmaceuticals
Bausch & Lomb
Novartis
Allergan
Alimera Sciences
ThromboGenics
Bristol-Myers Squibb

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

レポート目次

1 Market Overview
1.1 Intravitreal (IVT) Injectables Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Intravitreal (IVT) Injectables Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Anti-VEGF
1.2.3 Corticosteroids
1.2.4 Antibiotics
1.2.5 Antivirals
1.2.6 Antifungals
1.3 Market Analysis by Application
1.3.1 Overview: Global Intravitreal (IVT) Injectables Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Drug Stores
1.3.5 Mail Order Pharmacies
1.3.6 Others
1.4 Global Intravitreal (IVT) Injectables Market Size & Forecast
1.4.1 Global Intravitreal (IVT) Injectables Sales in Value (2016-2026))
1.4.2 Global Intravitreal (IVT) Injectables Sales in Volume (2016-2026)
1.4.3 Global Intravitreal (IVT) Injectables Price by Type (2016-2026) & (USD/Unit)
1.5 Global Intravitreal (IVT) Injectables Production Capacity Analysis
1.5.1 Global Intravitreal (IVT) Injectables Total Production Capacity (2016-2026)
1.5.2 Global Intravitreal (IVT) Injectables Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Intravitreal (IVT) Injectables Market Drivers
1.6.2 Intravitreal (IVT) Injectables Market Restraints
1.6.3 Intravitreal (IVT) Injectables Trends Analysis
2 Manufacturers Profiles
2.1 Regeneron Pharmaceuticals
2.1.1 Regeneron Pharmaceuticals Details
2.1.2 Regeneron Pharmaceuticals Major Business
2.1.3 Regeneron Pharmaceuticals Intravitreal (IVT) Injectables Product and Services
2.1.4 Regeneron Pharmaceuticals Intravitreal (IVT) Injectables Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Bausch & Lomb
2.2.1 Bausch & Lomb Details
2.2.2 Bausch & Lomb Major Business
2.2.3 Bausch & Lomb Intravitreal (IVT) Injectables Product and Services
2.2.4 Bausch & Lomb Intravitreal (IVT) Injectables Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Intravitreal (IVT) Injectables Product and Services
2.3.4 Novartis Intravitreal (IVT) Injectables Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Allergan
2.4.1 Allergan Details
2.4.2 Allergan Major Business
2.4.3 Allergan Intravitreal (IVT) Injectables Product and Services
2.4.4 Allergan Intravitreal (IVT) Injectables Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Alimera Sciences
2.5.1 Alimera Sciences Details
2.5.2 Alimera Sciences Major Business
2.5.3 Alimera Sciences Intravitreal (IVT) Injectables Product and Services
2.5.4 Alimera Sciences Intravitreal (IVT) Injectables Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 ThromboGenics
2.6.1 ThromboGenics Details
2.6.2 ThromboGenics Major Business
2.6.3 ThromboGenics Intravitreal (IVT) Injectables Product and Services
2.6.4 ThromboGenics Intravitreal (IVT) Injectables Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Bristol-Myers Squibb
2.7.1 Bristol-Myers Squibb Details
2.7.2 Bristol-Myers Squibb Major Business
2.7.3 Bristol-Myers Squibb Intravitreal (IVT) Injectables Product and Services
2.7.4 Bristol-Myers Squibb Intravitreal (IVT) Injectables Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Intravitreal (IVT) Injectables Sales by Manufacturer
3.1 Global Intravitreal (IVT) Injectables Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Intravitreal (IVT) Injectables Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Intravitreal (IVT) Injectables
3.4 Market Concentration Rate
3.4.1 Top 3 Intravitreal (IVT) Injectables Manufacturer Market Share
3.4.2 Top 6 Intravitreal (IVT) Injectables Manufacturer Market Share
3.5 Global Intravitreal (IVT) Injectables Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Intravitreal (IVT) Injectables Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Intravitreal (IVT) Injectables Market Size by Region
4.1.1 Global Intravitreal (IVT) Injectables Sales in Volume by Region (2016-2026)
4.1.2 Global Intravitreal (IVT) Injectables Revenue by Region (2016-2026)
4.2 North America Intravitreal (IVT) Injectables Revenue (2016-2026)
4.3 Europe Intravitreal (IVT) Injectables Revenue (2016-2026)
4.4 Asia-Pacific Intravitreal (IVT) Injectables Revenue (2016-2026)
4.5 South America Intravitreal (IVT) Injectables Revenue (2016-2026)
4.6 Middle East and Africa Intravitreal (IVT) Injectables Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Intravitreal (IVT) Injectables Sales in Volume by Type (2016-2026)
5.2 Global Intravitreal (IVT) Injectables Revenue by Type (2016-2026)
5.3 Global Intravitreal (IVT) Injectables Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Intravitreal (IVT) Injectables Sales in Volume by Application (2016-2026)
6.2 Global Intravitreal (IVT) Injectables Revenue by Application (2016-2026)
6.3 Global Intravitreal (IVT) Injectables Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Intravitreal (IVT) Injectables Sales by Type (2016-2026)
7.2 North America Intravitreal (IVT) Injectables Sales by Application (2016-2026)
7.3 North America Intravitreal (IVT) Injectables Market Size by Country
7.3.1 North America Intravitreal (IVT) Injectables Sales in Volume by Country (2016-2026)
7.3.2 North America Intravitreal (IVT) Injectables Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Intravitreal (IVT) Injectables Sales by Type (2016-2026)
8.2 Europe Intravitreal (IVT) Injectables Sales by Application (2016-2026)
8.3 Europe Intravitreal (IVT) Injectables Market Size by Country
8.3.1 Europe Intravitreal (IVT) Injectables Sales in Volume by Country (2016-2026)
8.3.2 Europe Intravitreal (IVT) Injectables Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Intravitreal (IVT) Injectables Sales by Type (2016-2026)
9.2 Asia-Pacific Intravitreal (IVT) Injectables Sales by Application (2016-2026)
9.3 Asia-Pacific Intravitreal (IVT) Injectables Market Size by Region
9.3.1 Asia-Pacific Intravitreal (IVT) Injectables Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Intravitreal (IVT) Injectables Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Intravitreal (IVT) Injectables Sales by Type (2016-2026)
10.2 South America Intravitreal (IVT) Injectables Sales by Application (2016-2026)
10.3 South America Intravitreal (IVT) Injectables Market Size by Country
10.3.1 South America Intravitreal (IVT) Injectables Sales in Volume by Country (2016-2026)
10.3.2 South America Intravitreal (IVT) Injectables Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Intravitreal (IVT) Injectables Sales by Type (2016-2026)
11.2 Middle East & Africa Intravitreal (IVT) Injectables Sales by Application (2016-2026)
11.3 Middle East & Africa Intravitreal (IVT) Injectables Market Size by Country
11.3.1 Middle East & Africa Intravitreal (IVT) Injectables Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Intravitreal (IVT) Injectables Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Intravitreal (IVT) Injectables Typical Distributors
12.3 Intravitreal (IVT) Injectables Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Intravitreal (IVT) Injectables Revenue by Type, (USD Million), 2021-2026
Table 2. Global Intravitreal (IVT) Injectables Revenue by Application, (USD Million), 2021-2026
Table 3. Regeneron Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. Regeneron Pharmaceuticals Major Business
Table 5. Regeneron Pharmaceuticals Intravitreal (IVT) Injectables Product and Services
Table 6. Regeneron Pharmaceuticals Intravitreal (IVT) Injectables Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Bausch & Lomb Basic Information, Manufacturing Base and Competitors
Table 8. Bausch & Lomb Major Business
Table 9. Bausch & Lomb Intravitreal (IVT) Injectables Product and Services
Table 10. Bausch & Lomb Intravitreal (IVT) Injectables Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Novartis Basic Information, Manufacturing Base and Competitors
Table 12. Novartis Major Business
Table 13. Novartis Intravitreal (IVT) Injectables Product and Services
Table 14. Novartis Intravitreal (IVT) Injectables Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Allergan Basic Information, Manufacturing Base and Competitors
Table 16. Allergan Major Business
Table 17. Allergan Intravitreal (IVT) Injectables Product and Services
Table 18. Allergan Intravitreal (IVT) Injectables Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Alimera Sciences Basic Information, Manufacturing Base and Competitors
Table 20. Alimera Sciences Major Business
Table 21. Alimera Sciences Intravitreal (IVT) Injectables Product and Services
Table 22. Alimera Sciences Intravitreal (IVT) Injectables Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. ThromboGenics Basic Information, Manufacturing Base and Competitors
Table 24. ThromboGenics Major Business
Table 25. ThromboGenics Intravitreal (IVT) Injectables Product and Services
Table 26. ThromboGenics Intravitreal (IVT) Injectables Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 28. Bristol-Myers Squibb Major Business
Table 29. Bristol-Myers Squibb Intravitreal (IVT) Injectables Product and Services
Table 30. Bristol-Myers Squibb Intravitreal (IVT) Injectables Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Global Intravitreal (IVT) Injectables Sales by Manufacturer (2019-2021e) & (K Units)
Table 32. Global Intravitreal (IVT) Injectables Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 33. Market Position of Manufacturers in Intravitreal (IVT) Injectables, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 34. Global Intravitreal (IVT) Injectables Production Capacity by Company, (K Units): 2020 VS 2021
Table 35. Head Office and Intravitreal (IVT) Injectables Production Site of Key Manufacturer
Table 36. Global Intravitreal (IVT) Injectables Sales by Region (2016-2021e) & (K Units)
Table 37. Global Intravitreal (IVT) Injectables Sales by Region (2021-2026) & (K Units)
Table 38. Global Intravitreal (IVT) Injectables Revenue by Region (2016-2021e) & (USD Million)
Table 39. Global Intravitreal (IVT) Injectables Revenue by Region (2021-2026) & (USD Million)
Table 40. Global Intravitreal (IVT) Injectables Sales by Type (2016-2021e) & (K Units)
Table 41. Global Intravitreal (IVT) Injectables Sales by Type (2021-2026) & (K Units)
Table 42. Global Intravitreal (IVT) Injectables Revenue by Type (2016-2021e) & (USD Million)
Table 43. Global Intravitreal (IVT) Injectables Revenue by Type (2021-2026) & (USD Million)
Table 44. Global Intravitreal (IVT) Injectables Price by Type (2016-2021e) & (USD/Unit)
Table 45. Global Intravitreal (IVT) Injectables Price by Type (2021-2026) & (USD/Unit)
Table 46. Global Intravitreal (IVT) Injectables Sales by Application (2016-2021e) & (K Units)
Table 47. Global Intravitreal (IVT) Injectables Sales by Application (2021-2026) & (K Units)
Table 48. Global Intravitreal (IVT) Injectables Revenue by Application (2016-2021e) & (USD Million)
Table 49. Global Intravitreal (IVT) Injectables Revenue by Application (2021-2026) & (USD Million)
Table 50. Global Intravitreal (IVT) Injectables Price by Application (2016-2021e) & (USD/Unit)
Table 51. Global Intravitreal (IVT) Injectables Price by Application (2021-2026) & (USD/Unit)
Table 52. North America Intravitreal (IVT) Injectables Sales by Country (2016-2021e) & (K Units)
Table 53. North America Intravitreal (IVT) Injectables Sales by Country (2021-2026) & (K Units)
Table 54. North America Intravitreal (IVT) Injectables Revenue by Country (2016-2021e) & (USD Million)
Table 55. North America Intravitreal (IVT) Injectables Revenue by Country (2021-2026) & (USD Million)
Table 56. North America Intravitreal (IVT) Injectables Sales by Type (2016-2021e) & (K Units)
Table 57. North America Intravitreal (IVT) Injectables Sales by Type (2021-2026) & (K Units)
Table 58. North America Intravitreal (IVT) Injectables Sales by Application (2016-2021e) & (K Units)
Table 59. North America Intravitreal (IVT) Injectables Sales by Application (2021-2026) & (K Units)
Table 60. Europe Intravitreal (IVT) Injectables Sales by Country (2016-2021e) & (K Units)
Table 61. Europe Intravitreal (IVT) Injectables Sales by Country (2021-2026) & (K Units)
Table 62. Europe Intravitreal (IVT) Injectables Revenue by Country (2016-2021e) & (USD Million)
Table 63. Europe Intravitreal (IVT) Injectables Revenue by Country (2021-2026) & (USD Million)
Table 64. Europe Intravitreal (IVT) Injectables Sales by Type (2016-2021e) & (K Units)
Table 65. Europe Intravitreal (IVT) Injectables Sales by Type (2021-2026) & (K Units)
Table 66. Europe Intravitreal (IVT) Injectables Sales by Application (2016-2021e) & (K Units)
Table 67. Europe Intravitreal (IVT) Injectables Sales by Application (2021-2026) & (K Units)
Table 68. Asia-Pacific Intravitreal (IVT) Injectables Sales by Region (2016-2021e) & (K Units)
Table 69. Asia-Pacific Intravitreal (IVT) Injectables Sales by Region (2021-2026) & (K Units)
Table 70. Asia-Pacific Intravitreal (IVT) Injectables Revenue by Region (2016-2021e) & (USD Million)
Table 71. Asia-Pacific Intravitreal (IVT) Injectables Revenue by Region (2021-2026) & (USD Million)
Table 72. Asia-Pacific Intravitreal (IVT) Injectables Sales by Type (2016-2021e) & (K Units)
Table 73. Asia-Pacific Intravitreal (IVT) Injectables Sales by Type (2021-2026) & (K Units)
Table 74. Asia-Pacific Intravitreal (IVT) Injectables Sales by Application (2016-2021e) & (K Units)
Table 75. Asia-Pacific Intravitreal (IVT) Injectables Sales by Application (2021-2026) & (K Units)
Table 76. South America Intravitreal (IVT) Injectables Sales by Country (2016-2021e) & (K Units)
Table 77. South America Intravitreal (IVT) Injectables Sales by Country (2021-2026) & (K Units)
Table 78. South America Intravitreal (IVT) Injectables Revenue by Country (2016-2021e) & (USD Million)
Table 79. South America Intravitreal (IVT) Injectables Revenue by Country (2021-2026) & (USD Million)
Table 80. South America Intravitreal (IVT) Injectables Sales by Type (2016-2021e) & (K Units)
Table 81. South America Intravitreal (IVT) Injectables Sales by Type (2021-2026) & (K Units)
Table 82. South America Intravitreal (IVT) Injectables Sales by Application (2016-2021e) & (K Units)
Table 83. South America Intravitreal (IVT) Injectables Sales by Application (2021-2026) & (K Units)
Table 84. Middle East & Africa Intravitreal (IVT) Injectables Sales by Country (2016-2021e) & (K Units)
Table 85. Middle East & Africa Intravitreal (IVT) Injectables Sales by Country (2021-2026) & (K Units)
Table 86. Middle East & Africa Intravitreal (IVT) Injectables Revenue by Country (2016-2021e) & (USD Million)
Table 87. Middle East & Africa Intravitreal (IVT) Injectables Revenue by Country (2021-2026) & (USD Million)
Table 88. Middle East & Africa Intravitreal (IVT) Injectables Sales by Type (2016-2021e) & (K Units)
Table 89. Middle East & Africa Intravitreal (IVT) Injectables Sales by Type (2021-2026) & (K Units)
Table 90. Middle East & Africa Intravitreal (IVT) Injectables Sales by Application (2016-2021e) & (K Units)
Table 91. Middle East & Africa Intravitreal (IVT) Injectables Sales by Application (2021-2026) & (K Units)
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Intravitreal (IVT) Injectables Typical Distributors
Table 95. Intravitreal (IVT) Injectables Typical Customers
List of Figures
Figure 1. Intravitreal (IVT) Injectables Picture
Figure 2. Global Intravitreal (IVT) Injectables Sales Market Share by Type in 2020
Figure 3. Anti-VEGF
Figure 4. Corticosteroids
Figure 5. Antibiotics
Figure 6. Antivirals
Figure 7. Antifungals
Figure 8. Global Intravitreal (IVT) Injectables Sales Market Share by Application in 2020
Figure 9. Hospital Pharmacies
Figure 10. Retail Pharmacies
Figure 11. Drug Stores
Figure 12. Mail Order Pharmacies
Figure 13. Others
Figure 14. Global Intravitreal (IVT) Injectables Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 15. Global Intravitreal (IVT) Injectables Market Size and Forecast (2016-2026) & (USD Million)
Figure 16. United States Intravitreal (IVT) Injectables Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Canada Intravitreal (IVT) Injectables Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Mexico Intravitreal (IVT) Injectables Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Germany Intravitreal (IVT) Injectables Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. France Intravitreal (IVT) Injectables Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. United Kingdom Intravitreal (IVT) Injectables Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Russia Intravitreal (IVT) Injectables Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Italy Intravitreal (IVT) Injectables Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. China Intravitreal (IVT) Injectables Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Japan Intravitreal (IVT) Injectables Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Korea Intravitreal (IVT) Injectables Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. India Intravitreal (IVT) Injectables Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Southeast Asia Intravitreal (IVT) Injectables Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Australia Intravitreal (IVT) Injectables Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Brazil Intravitreal (IVT) Injectables Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Egypt Intravitreal (IVT) Injectables Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Saudi Arabia Intravitreal (IVT) Injectables Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. South Africa Intravitreal (IVT) Injectables Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. Turkey Intravitreal (IVT) Injectables Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. Global Intravitreal (IVT) Injectables Sales (2016-2026) & (K Units)
Figure 36. Global Intravitreal (IVT) Injectables Production Capacity (2016-2026) & (K Units)
Figure 37. Global Intravitreal (IVT) Injectables Production Capacity by Geographic Region: 2020 VS 2021
Figure 38. Intravitreal (IVT) Injectables Market Drivers
Figure 39. Intravitreal (IVT) Injectables Market Restraints
Figure 40. Intravitreal (IVT) Injectables Market Trends
Figure 41. Global Intravitreal (IVT) Injectables Sales Market Share by Manufacturer in 2020
Figure 42. Global Intravitreal (IVT) Injectables Revenue Market Share by Manufacturer in 2020
Figure 43. Intravitreal (IVT) Injectables Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 44. Top 3 Intravitreal (IVT) Injectables Manufacturer (Revenue) Market Share in 2020
Figure 45. Top 6 Intravitreal (IVT) Injectables Manufacturer (Revenue) Market Share in 2020
Figure 46. Global Intravitreal (IVT) Injectables Sales Market Share by Region (2016-2026)
Figure 47. Global Intravitreal (IVT) Injectables Revenue Market Share by Region (2016-2026)
Figure 48. North America Intravitreal (IVT) Injectables Revenue (2016-2026) & (USD Million)
Figure 49. Europe Intravitreal (IVT) Injectables Revenue (2016-2026) & (USD Million)
Figure 50. Asia-Pacific Intravitreal (IVT) Injectables Revenue (2016-2026) & (USD Million)
Figure 51. South America Intravitreal (IVT) Injectables Revenue (2016-2026) & (USD Million)
Figure 52. Middle East & Africa Intravitreal (IVT) Injectables Revenue (2016-2026) & (USD Million)
Figure 53. Global Intravitreal (IVT) Injectables Sales Market Share by Type (2016-2026)
Figure 54. Global Intravitreal (IVT) Injectables Revenue Market Share by Type (2016-2026)
Figure 55. Global Intravitreal (IVT) Injectables Price by Type (2016-2026) & (USD/Unit)
Figure 56. Global Intravitreal (IVT) Injectables Sales Market Share by Application (2016-2026)
Figure 57. Global Intravitreal (IVT) Injectables Revenue Market Share by Application (2016-2026)
Figure 58. Global Intravitreal (IVT) Injectables Price by Application (2016-2026) & (USD/Unit)
Figure 59. North America Intravitreal (IVT) Injectables Sales Market Share by Country (2016-2026)
Figure 60. North America Intravitreal (IVT) Injectables Revenue Market Share by Country (2016-2026)
Figure 61. North America Intravitreal (IVT) Injectables Sales Market Share by Type (2016-2026)
Figure 62. North America Intravitreal (IVT) Injectables Sales Market Share by Application (2016-2026)
Figure 63. Europe Intravitreal (IVT) Injectables Sales Market Share by Country (2016-2026)
Figure 64. Europe Intravitreal (IVT) Injectables Revenue Market Share by Country (2016-2026)
Figure 65. Europe Intravitreal (IVT) Injectables Sales Market Share by Type (2016-2026)
Figure 66. Europe Intravitreal (IVT) Injectables Sales Market Share by Application (2016-2026)
Figure 67. Asia-Pacific Intravitreal (IVT) Injectables Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Intravitreal (IVT) Injectables Revenue Market Share by Region (2016-2026)
Figure 69. Asia-Pacific Intravitreal (IVT) Injectables Sales Market Share by Region (2016-2026)
Figure 70. Asia-Pacific Intravitreal (IVT) Injectables Sales Market Share by Application (2016-2026)
Figure 71. South America Intravitreal (IVT) Injectables Sales Market Share by Country (2016-2026)
Figure 72. South America Intravitreal (IVT) Injectables Revenue Market Share by Country (2016-2026)
Figure 73. South America Intravitreal (IVT) Injectables Sales Market Share by Type (2016-2026)
Figure 74. South America Intravitreal (IVT) Injectables Sales Market Share by Application (2016-2026)
Figure 75. Middle East & Africa Intravitreal (IVT) Injectables Sales Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Intravitreal (IVT) Injectables Revenue Market Share by Country (2016-2026)
Figure 77. Middle East & Africa Intravitreal (IVT) Injectables Sales Market Share by Type (2016-2026)
Figure 78. Middle East & Africa Intravitreal (IVT) Injectables Sales Market Share by Application (2016-2026)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source